Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05443399 · ClinicalTrials.gov registry record · NA

What Makes a Cup, a Cup? Generalizing Novel Words

A NA study, sponsored by Oklahoma State University.

Completed
Registry status
NA
Development phase
212
Enrollment target

NCT05443399: Completed NA study, sponsored by Oklahoma State University.

NCT05443399 is a NA study that has completed, run by Oklahoma State University. The registered enrollment target is 212 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05443399, a NA study, has completed, sponsored by Oklahoma State University.

COMPLETED
Registry status
NA
Development phase
212 participants
Enrollment target

Study Summary

The goal of this work is to address increasing concerns about young children's digital media exposure and language outcomes by testing how the times course of word learning unfolds in digital environments and the cascading impact of digital media on vocabulary outcomes. The findings will have important implications for understanding when and where optimal word learning from media can occur.

Primary Outcome

Accuracy on selecting the target item on novel noun generalization task, defined as percent of choices to the shape-matching item across all trials

Interventions

  • BEHAVIORAL Modality - 3D-2D
  • BEHAVIORAL Modality - 2D-3D
  • BEHAVIORAL Modality - 2D-2D

Trial Details

FieldValue
Enrollment Target 212 participants
Start Date 2022-04-07
Est. Completion 2025-04-30
Phase NA
Oklahoma State University

26 total trials

What the finished NCT05443399 record still lists

NCT05443399 is an interventional study that assigns participants to a tested intervention. The registered 212 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).

The record links to 0 conditions, and to 3 interventions - of which Modality - 3D-2D is the first listed.

NCT05443399 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05443399 about?

NCT05443399 is a clinical study titled "What Makes a Cup, a Cup? Generalizing Novel Words". The goal of this work is to address increasing concerns about young children's digital media exposure and language outcomes by testing how the times course of word learning unfolds in digital environments and the cascading impact of digital media on vocabulary outcomes. The findings will have import...

What is the current status of trial NCT05443399?

This trial is currently completed. It is a NA study. The enrollment target is 212 participants. The study started on 2022-04-07. Estimated completion is 2025-04-30.

What interventions are being tested in trial NCT05443399?

The interventions under investigation include: Modality - 3D-2D (BEHAVIORAL), Modality - 2D-3D (BEHAVIORAL), Modality - 2D-2D (BEHAVIORAL).

Who is sponsoring clinical trial NCT05443399?

This trial is sponsored by Oklahoma State University, which has 26 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05443399's enrollment target sits among peer trials

212 489th of 2000 higher than 1,511 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04228978 · 212 participants · NA

    Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss

  • NCT04725721 · 212 participants · NA

    Testing FIRST in Youth Outpatient Psychotherapy

  • NCT06257576 · 212 participants · Phase 3

    Function of Tamsulosin in Older Males Undergoing Surgery with Indwelling Catheter

  • NCT06456593 · 212 participants · Phase 2

    Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05443399, the US trial registry maintained by the National Library of Medicine. NCT05443399 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.